Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.

Slides:



Advertisements
Similar presentations
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
Advertisements

PCI VS CABG JOURNAL REVIEW
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Published in Circulation 2003 Rory Hachamovitch, MD, MSc; Sean W. Hayes, MD; John D. Friedman, MD; Ishac Cohen PhD; Daniel S. Berman, MD Comparison of.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. Patterns and Predictors of Stress Testing Modality After.
Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Peripheral Artery Disease: Evolving Role of Exercise,
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Thrombectomy for Acute Ischemic Stroke:
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Elevated Plasma Levels of Neuropeptide Proenkephalin.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prediction of Cardiac Events in Patients With Reduced.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Cardiac Computed Tomography.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiovascular Imaging Research at the Crossroads.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: When to stress patients after coronary artery bypass.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic implications of atrial fibrillation in.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Overview of the 2011 Food and Drug Administration.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Limitations of Ejection Fraction for Prediction.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Clinical Implications of Newly Revealed,
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Clinical Results Following Stenting of.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Multislice Computed Tomography.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Outcomes and Cost-Effectiveness of Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Procedural Outcomes of Chronic Total Occlusion Percutaneous.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Non–ST-Segment Elevation Acute Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Benefit of Early Invasive Therapy in Acute Coronary.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
From: Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effectiveness of In-Laboratory High-Dose Clopidogrel.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology The Elusive Role of Myocardial Perfusion Imaging in.
Copyright © 2006 American Medical Association. All rights reserved.
Catheter-Based Treatment of Coronary Artery Disease
Dual Goals for the Management of Stable Ischemic Heart Disease (SIHD)
Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Presentation transcript:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Propensity-Matched Analysis in 39,131 Canadian Patients With SIHD Undergoing Early Revascularization (n = 23,992) or Treated Conservatively (n = 15,139) Over 4 years of follow-up, significant reductions in death (A) and myocardial infarction (B) were observed with revascularization. CI = confidence interval; HR = hazard ratio; SIHD = stable ischemic heart disease. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Cardiac Mortality as a Function of Total Ischemic Myocardium at a Mean Follow-Up Time of 1.9 ± 0.6 Years Cardiac mortality as a function of total ischemic myocardium is shown at a mean follow-up time of 1.9 ± 0.6 years in 10,627 patients at Cedars-Sinai Medical Center without previous myocardial infarction or revascularization who underwent exercise or adenosine thallium 201 single-photon emission computed tomography myocardial perfusion scintigraphy. Outcomes are shown according to whether elective revascularization was versus was not performed within 60 days. Patients with a greater percentage of ischemic myocardium had a greater survival benefit with revascularization. (A) Unadjusted analysis. (B) Log hazard ratio of cardiac mortality for revascularization versus medical therapy as a function of % ischemic myocardium from a Cox proportional hazards regression model. *p < Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Reduction in Inducible Ischemia From Baseline to 6 to 18 Months Reduction in inducible ischemia from baseline to 6 to 18 months is shown in patients treated with OMT with versus without a strategy of routine upfront PCI, as assessed by myocardial perfusion scintigraphy. Left graph: with routine upfront PCI; right graph: without. The reduction in ischemia in the PCI arm was significant, whereas there was no significant reduction in ischemia with OMT. CI = confidence interval; OMT = optimal medical therapy; PCI = percutaneous coronary intervention. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Relationship Between FFR and 1-Year MACE According to Whether or Not Revascularization Was Performed (A) Study-level meta-regression in 8,418 patients from 90 cohorts. Revascularization was associated with a lower rate of MACE when the FFR was <0.75 in an unadjusted random effects model, and <0.90 in an adjusted model. (B) Patient-level meta-analysis in 5,979 patients. Revascularization was associated with a lower rate of MACE when the FFR was <0.67 in an unadjusted Cox model, and <0.76 in an adjusted model. CABG = coronary artery bypass graft; FFR = fractional flow reserve; MACE = major adverse cardiac events; MI = myocardial infarction; PCI = percutaneous coronary intervention. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Network Meta-Analysis Comparing Different Revascularization Modalities With MT Estimated risk rate ratios (95% credible intervals) are shown for death, MI, and the composite of death or MI. Compared with MT, a reduction in death was observed with EES, R-ZES, and CABG; a reduction in MI was observed with CABG; and a reduction in the composite of death or MI was observed with EES and CABG. BMS = bare-metal stent(s); CrI = credible interval; EES = everolimus- eluting stent(s); E-ZES = fast-release zotarolimus-eluting stent(s); MT = medical therapy; PES = paclitaxel-eluting stent(s); PTCA = percutaneous transluminal coronary angioplasty; R-ZES = slow-release zotarolimus eluting stent(s); SES = sirolimus-eluting stent(s); other abbreviations as in Figure 4. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Effect of OMT on Clinical Outcomes in Patients Undergoing PES Implantation and CABG in the SYNTAX Trial OMT significantly lowered the risk of death throughout the 5-year follow-up. In a Cox regression model, OMT as a time-dependent covariate was independently associated with improved survival throughout follow-up both in PCI patients (HR: 0.70; 95% CI: 0.48 to 0.998) and CABG patients (HR: 0.65; 95% CI: 0.49 to 0.86; pinteraction = 0.44). SYNTAX = Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery; other abbreviations as in Figures 1, 3, 4, and 5. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Baseline Severity of Ischemia and Outcomes by Treatment Group in the COURAGE Trial Cumulative rates of all-cause death or MI are shown according to randomized treatment assignment in patients with no-to-mild ischemia and moderate-to-severe ischemia on myocardial perfusion imaging at baseline in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. (A) No-to-mild ischemia. (B) Moderate-to-severe ischemia. Ischemia severity was determined by the participating sites, and was not associated with risk of death or MI. PCI did not reduce death or MI in patients with moderate or severe ischemia. Abbreviations as in Figures 3 and 4. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Ischemia Severity, Anatomic Burden, and Outcomes in COURAGE Freedom from death, MI, or NSTE-ACS is shown by percent ischemic myocardium and burden of angiographic atherosclerosis. (A) Percent ischemic myocardium. (B) Burden of angiographic atherosclerosis. The number of patients pertaining to each colored curve is shown per year of follow-up. The Cedars-Sinai Nuclear Core Laboratory determined the percent ischemic myocardium at baseline. Atherosclerotic burden was determined by a custom score, accounting for the number and specific diseased coronary arteries, and proximal versus nonproximal location. Ischemic burden was not associated with events, in contrast to anatomic burden, which was. PCI did not reduce the event rate in patients with high ischemic or anatomic burden. NSTE-ACS = non–ST-segment elevation acute coronary syndrome; other abbreviations as in Figures 3, 4, and 7. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Meta-Analysis of PCI and MT Versus MT Alone in Patients With Documented Myocardial Ischemia (A) Death. (B) Nonfatal MI. This meta-analysis required 50% statin use and only included studies of SIHD that directly compared the 2 randomized groups. The addition of PCI to MT did not reduce the incidence of death or MI as compared with MT alone. OR = odds ratio; other abbreviations as in Figures 3, 4, and 5. Figure Legend:

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise J Am Coll Cardiol. 2016;67(1): doi: /j.jacc Ischemia Revascularization Equipoise: The ISCHEMIA Trial Design CCTA may not be performed in participants with estimated glomerular filtration rate <60 ml/min. Participants in whom CCTA shows significant left main disease (≥50% stenosis) or no obstructive disease are excluded. CCTA results are otherwise kept blinded. Cath = catheterization; CCTA = coronary computed tomographic angiography; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; OMT = optimal medical therapy; SIHD = stable ischemic heart disease. Figure Legend: